Literature DB >> 1659276

Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.

D J Margolskee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1659276     DOI： 10.1111/j.1749-6632.1991.tb37972.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.

Authors:  J I Schwartz; D J Margolskee; T D Bjornsson; V C Williams; J Y Hsieh; C C Lin; J D Rogers
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

2.  The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study.

Authors:  Severin Mairinger; Jens P Bankstahl; Claudia Kuntner; Kerstin Römermann; Marion Bankstahl; Thomas Wanek; Johann Stanek; Wolfgang Löscher; Markus Müller; Thomas Erker; Oliver Langer
Journal:  Epilepsy Res       Date:  2012-02-17       Impact factor: 3.045

3.  Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits.

Authors:  D W Nicholson; A Ali; J P Vaillancourt; J R Calaycay; R A Mumford; R J Zamboni; A W Ford-Hutchinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

4.  Molecular cloning and expression of human leukotriene-C4 synthase.

Authors:  D J Welsch; D P Creely; S D Hauser; K J Mathis; G G Krivi; P C Isakson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

5.  Intracellular delivery of nanoparticles of an antiasthmatic drug.

Authors:  Naazneen Surti; Sachin Naik; Tamishraha Bagchi; B S Dwarkanath; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2008-02-07       Impact factor: 3.246

6.  Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.

Authors:  M Depré; D J Margolskee; A Van Hecken; J S Hsieh; A Buntinx; P J De Schepper; J D Rogers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.